	Evaluating the Long-Term Benefits of Medications for Alcohol Use Disorder in Alcohol-Associated Cirrhosis. Liver Int Niu C, Zhang J, Idoate-Domench DJ, Rao AV, Sanjeevi A, Joshi U, Zhu K, Jadhav N, Daglilar E, Okolo P. PMID: 41190460 [PubMed - indexed for MEDLINE]
	The use of magnesium sulfate can reduce the mortality risk of cirrhosis patients: a retrospective cohort study. Front Pharmacol Chen B, Yang Y, Liang M, Kou Y, Ye R, Zhan L, Huang Y, Zhang Q, Huang H, Zheng J, Huang Z, Ye S. PMID: 41190021 [PubMed]
	CardioHepatology: Exploring the Interplay Between Cirrhosis, Cirrhotic Cardiomyopathy, Coronary Artery Disease, and Liver Transplantation. Heart Lung Circ Brick CR, Cailes B, Majumdar A, Testro A, Sinclair M, Al-Fiadh A, Weinberg L, Ramachandran J, Gill M, Farouque O, Koshy AN. PMID: 41188159 [PubMed - as supplied by publisher]
	Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib. J Drugs Dermatol Zhou AE, Ravi S, Murphy M, Lu J, Ferenczi K. PMID: 41187239 [PubMed - indexed for MEDLINE]
	Predictive value of neutrophil to lymphocyte ratio for clinical outcomes in liver cirrhosis: A systematic review and meta-analysis. PLoS One Lin J, Huang M, Shen L. PMID: 41187160 [PubMed - indexed for MEDLINE]
	Predicting esophageal varices in cirrhosis: diagnostic utility of MR elastography and dynamic contrast-enhanced MRI. Abdom Radiol (NY) Singwicha T, Chansaengpetch S, Tanpowpong N. PMID: 41186713 [PubMed - as supplied by publisher]
	Rapid detection of Golgi protein 73 by MAGLUMI chemiluminescent immunoassay and the clinical value to liver fibrosis/cirrhosis patients with chronic liver disease. Front Cell Infect Microbiol Wang L, Dai W, Rao J, Wang Y, Liu K, Li X, Wang H, Ye J, Fang Z, Zheng X. PMID: 41181317 [PubMed - indexed for MEDLINE]
	Multiparametric ultrasound for the prediction of the short-term outcome after esophageal varices band ligation. World J Gastroenterol Ainora ME, Borriello R, Pecere S, Paratore M, Galasso L, Calvez V, Esposto G, Mignini I, Barbaro F, Del Vecchio LE, Ponziani FR, Annicchiarico BE, Garcovich M, Riccardi L, Pompili M, Spada C, Gasbarrini A, Zocco MA. PMID: 41180996 [PubMed - indexed for MEDLINE]
	Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma. World J Gastroenterol Villa E, Donghia R, Coletta S, Bonfiglio C, Critelli RM, Ancona A, Shahini E, Iacovazzi PA, Cozzolongo R, Pavone F, Carella N, Pontisso P, Martini A, Al Aoua S, Bantel H, Giannelli G. PMID: 41180985 [PubMed - indexed for MEDLINE]
	Clinical impact of multidrug-resistant organisms in liver cirrhosis: A retrospective cohort study in the intensive care setting. World J Gastroenterol Kosuta I, Babel J, Domislovic V, Susak F, Peretin L, Varda Brkic D, Marekovic I, Radonic R, Mrzljak A. PMID: 41180792 [PubMed - indexed for MEDLINE]
	Current clinical research status and future treatment directions for liver cirrhosis combined with portal vein thrombosis. World J Hepatol He WL, Yan S, Lu JJ, Chen L, Wu JZ. PMID: 41179734 [PubMed]
	Hepatic hydrothorax as a manifestation of decompensated cirrhosis: An update on current management and future directions. World J Hepatol Cilia BJ, Haridy J, Raj A, Hannah N. PMID: 41179726 [PubMed]
	Improved clinical outcomes following embolization of extrahepatic portosystemic shunts in cirrhotic patients with recurrent hepatic encephalopathy. World J Hepatol Park JW, Kim Y, Lee JS, Jung IS, Kim KB, Chae HB. PMID: 41179724 [PubMed]
	Effect of empagliflozin on fractional excretion of sodium in patients with cirrhosis and refractory ascites. World J Hepatol Gao Y, Gao YY, Shi RY, Ji D, Wang Y, Xu L, Wang Q, Wu MH, You HL, Bu QS, Dong YX, Zhou LZ, Liu W, Song QK, Han Y, Wei H, Zhang XY, Hu ZJ. PMID: 41179718 [PubMed]
	Telerehabilitation for frail cirrhotic patients awaiting liver transplant: A safe, effective strategy to improve outcomes. World J Hepatol Loschi TM, Baccan MDTA, Pereira EC, Dellabarba TDLC, Boteon APCS, Boteon YL. PMID: 41179717 [PubMed]
	A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention. Liver Int Vega-Abellaneda S, Román E, Soler Z, Ortiz MÀ, Rossi G, Biagini L, Sánchez E, Pons-Tarin M, Laghi L, Mengucci C, Kaur N, Poca M, Cuyàs B, Serrano-Gomez G, Alvarado E, Manichanh C, Soriano G. PMID: 41174950 [PubMed - indexed for MEDLINE]
	New perspectives in the treatment of liver cirrhosis: targeting macrophage regulatory mechanisms. J Transl Med Zheng S, Li S, Wang Q, Zao X, Li X, Qi W, Cheng F, Geng Y, Zhang P, Shi X, Ye Y. PMID: 41174741 [PubMed - in process]
	Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol Trauner M, Levy C, Tanaka A, Goodman Z, Thorburn D, Joshi D, Salminen K, Yimam K, Isayama H, Montano-Loza AJ, Caldwell S, Danta M, Farkkila M, Gallegos-Orozco JF, Gordon SC, Hinrichsen H, Invernizzi P, Vuppalanchi R, Zhu K, Xu J, Liu X, Lu X, Crans G, Bolbolan S, Boyette L, Alani M, Barchuk WT, Watkins TR, Genovese MC, Bowlus CL. PMID: 41173015 [PubMed - as supplied by publisher]
	Risk factors and prediction model for sarcopenia in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt. Intern Emerg Med Tuo S, Yuan J, Liu Y, Wen Z, Ran Q, Li Y, Li C, Yang Q, Wang J, Li L, Dai S, Tantai X. PMID: 41171554 [PubMed - as supplied by publisher]
	Effect of bone marrow mononuclear cells therapy on long-term survival of patients with liver cirrhosis: A 10-year retrospective cohort study using propensity score matching. J Transl Int Med Ruan M, Yin Y, Ning W, Zhang B, Lin H, Yu H, Wang X, Zou D, Shao X, Chen J, Li H, Guo X, Qi X. PMID: 41169528 [PubMed]

Articles 1 - 20 / 37127

Page 1 of 1857



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy